Crossref
The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application
Aging Pathobiology and Therapeutics · 25.06.2026 · 8 (2)
DOI: 10.31491/apt.2026.06.227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, online erschienen am 30.06.2026. Verfasst von Chang-Hun Jung.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jung, C. (2026). The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application. Aging Pathobiology and Therapeutics, 8(2). https://doi.org/10.31491/apt.2026.06.227
Vancouver
Jung C. The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application. Aging Pathobiology and Therapeutics. 2026;8(2). doi:10.31491/apt.2026.06.227
BibTeX
@article{Jung2026,
author = {Jung, Chang-Hun},
title = {The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application},
journal = {Aging Pathobiology and Therapeutics},
year = {2026},
volume = {8},
number = {2},
doi = {10.31491/apt.2026.06.227}
}
EUVIMED